http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102558167-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7826e82a59639f553bfb024dfb2a0ea5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b30314450eb972d35cee920dd0ac8ffc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6447bce5bf1753fd23f4b65c0e77e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e219455fa6b3c658724702a3349a8ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11808152be0b162e1260f139541b6436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f83bde546e8ad5074898d5a7ad2f935a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8de7fe34f3cb0051a651f9d653cb46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff122672aa890c0eda1293c0c8ab48dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5932afbca8333237f374bc4c1680391
publicationDate 2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102558167-A
titleOfInvention Thiazolidine derivant with GK and PPAR double excitation activity
abstract The invention discloses a novel thiazolidine derivant and a preparation method, a medicine combination and a purpose thereof, which specifically relate to the thiazolidine derivant shown as the formula I and the formula II, officinal salt of the derivant, a precursor or a derivant with the same biological function with the thiazolidine derivant, the preparation method of the thiazolidine derivant, the combination of one or a plurality of thiazolidine derivants and the purpose of the compound in treatment on diseases related with glucokinase and a peroxisome proliferators activated receptor, such as diabetes mellitus and obesity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102727489-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I761681-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104610143-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I785351-B
priorityDate 2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464949771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465130580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465760358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71483841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466740169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71483838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465750442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71483839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465159631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16392076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71483735

Total number of triples: 44.